Management of critically-ill cirrhotic patients

https://doi.org/10.1016/S0168-8278(12)60003-8Get rights and content

Summary

Cirrhotic patients are prone to develop life-threatening complications that require emergency care and ICU admission. They can present specific decompensations related to cirrhosis such as variceal bleeding and hepatorenal syndrome (HRS) or other critical events also observed in the general population such as severe sepsis or septic shock. Clinical management of all these entities requires a specific approach in cirrhosis. Cirrhotic patients have a hyperdynamic circulation with high cardiac output and low systemic vascular resistance in the absence of infection [1,2]. Circulatory dysfunction increases the susceptibility of critically-ill cirrhotic patients to develop multiple organ failure and attenuates vascular reactivity to vasopressor drugs [3]. HRS, a severe functional renal failure occurring in patients with advanced cirrhosis and ascites, is also secondary to this circulatory dysfunction that leads to an extreme renal vasoconstriction [2]. Moreover, hypotensive cirrhotic patients require a carefully balanced replacement of volemia, since overtransfusion increases portal hypertension and the risk of variceal bleeding and undertransfusion causes tissue hypoperfusion which increases the risk of multiple organ failure [4,5]. Cirrhotic patients are also at a high risk for development of other bleeding complications and are more susceptible to nosocomial infections [6,7]. This extreme complexity of critically-ill cirrhotic patients requires a specific medical approach that should be known by general intensivists since it has a negative impact on patient prognosis. This review will focus on the diagnostic approach and treatment strategies currently recommended in the critical care management of patients with cirrhosis.

References (102)

  • I Khamaysi et al.

    Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: a randomized controlled study

    J Hepatol

    (2011)
  • T Lisman et al.

    Hemostasis and thrombosis in patients with liver disease: the ups and downs

    J Hepatol

    (2010)
  • C Fagundes et al.

    Acute kidney injury network (AKIN) criteria for acute renal failure predicts outcome in hospitalized cirrhotic patients. A prospective study

    J Hepatol

    (2011)
  • C Terra et al.

    Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score

    Gastroenterology

    (2005)
  • A Cárdenas et al.

    Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, predictive factors, and short-term prognosis

    Hepatology

    (2001)
  • A Ginès et al.

    Incidence and predictive factors of the hepatorenal syndrome in cirrhosis with ascites

    Gastroenterology

    (1993)
  • C Francoz et al.

    The evaluation of renal function and disease in patients with cirrhosis

    J Hepatol

    (2010)
  • V Arroyo et al.

    Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. The International Ascites Club Criteria

    Hepatology

    (1996)
  • A Sanyal et al.

    A randomized, prospective, double blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS)

    Gastroenterology

    (2008)
  • M Martin-Llahi et al.

    Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study

    Gastroenterology

    (2008)
  • K Rifai et al.

    Extracorporeal liver support by fractionated plasma separation and absorption (Prometheus) in patients with acute-on-chronic liver failure (HELIOS study): a prospective randomized controlled multicenter study. Abstracts of the 45th Annual Meeting of the European Association for the Study of the Liver (EASL)

    J Hepatol

    (2010)
  • T Restuccia et al.

    Effects of treatment of hepatorenal syndrome before transplantation on posttransplatation outcome. A case-control study

    J Hepatol

    (2004)
  • AT Blei et al.

    Hepatic encephalopathy

    Am J Gastroenterol

    (2001)
  • A Mas et al.

    Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

    J Hepatol

    (2003)
  • J Córdoba et al.

    Normal protein diet for episodic hepatic encephalopathy: results of a randomized study

    J Hepatol

    (2004)
  • S Sen et al.

    Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis

    J Hepatol

    (2005)
  • U Heemann et al.

    Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study

    Hepatology

    (2002)
  • SR Mitzner et al.

    Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

    Liver Transpl

    (2000)
  • J Fichet et al.

    Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy

    J Crit Care

    (2009)
  • PS Kamath et al.

    A model to predict survival in patients with end-stage liver disease

    Hepatology

    (2001)
  • F Durand et al.

    Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD

    J Hepatol

    (2005)
  • M Wehler et al.

    Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems

    Hepatology

    (2001)
  • RW Schrier et al.

    Peripheral arterial vasodilation hipótesis: a proposal for the initiation of renal sodium and water retention in cirrosis

    Hepatology

    (1998)
  • V Arroyo et al.

    Pathogenesis and treatment of hepatorenal syndrome

    Semin Liver Dis

    (2008)
  • A Albillos et al.

    Enhanced endothelium-dependent vasodilation in patients with cirrhosis

    Am J Physiol

    (1995)
  • P Tandon et al.

    Bacterial infections, sepsis, and multiorgan failure in cirrhosis

    Semin Liver Dis

    (2008)
  • T Gustot et al.

    Severe sepsis in cirrhosis

    Hepatology

    (2009)
  • N Carbonell et al.

    Improved survival after variceal bleeding in patients with cirrhosis over the past two decades

    Hepatology

    (2004)
  • G Garcia-Tsao et al.

    Portal hypertension and variceal bleeding-unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference

    Hepatology

    (2008)
  • J Bosch et al.

    Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial

    Hepatology

    (2008)
  • N Carbonell et al.

    Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial

    Am J Gastroenterol

    (2006)
  • D Pateron et al.

    Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial

    Ann Emerg Med

    (2011)
  • G D'Amico et al.

    Pharmacological treatment of portal hypertension: an evidence-based approach

    Semin Liver Dis

    (1999)
  • GN Ioannou et al.

    Systematic review: terlipressin in acute oesophageal variceal haemorrhage

    Aliment Pharmacol Ther

    (2003)
  • B Bernard et al.

    Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

    Hepatology

    (1999)
  • NC Chavez-Tapia et al.

    Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding

    Cochrane Database Syst Rev

    (2010)
  • P Sharma et al.

    Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose

    J Gastroenterol Hepatol

    (2010)
  • R de Franchis et al.

    Endoscopic treatments for portal hypertension

    Semin Liver Dis

    (1999)
  • JC Garcia-Pagan et al.

    Early use of TIPS in patients with cirrhosis and variceal bleeding

    N Engl J Med

    (2010)
  • J Zehetner et al.

    Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent

    Surg Endosc

    (2008)
  • Cited by (104)

    • Decompensated liver cirrhosis

      2024, Anaesthesia and Intensive Care Medicine
    • Decompensated liver cirrhosis

      2021, Anaesthesia and Intensive Care Medicine
      Citation Excerpt :

      Goal-directed therapy is advocated, but specific targets in cirrhotic patients have not been defined. Targets for this patient group may well differ from the general population due to differences in baseline physiology (e.g. cirrhotic patients often have a lower baseline MAP, urine output and haematocrit).7 Approximately 10% of in-patients with ascites will develop spontaneous bacterial peritonitis (SBP).

    View all citing articles on Scopus
    View full text